Navigation Links
BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Date:10/27/2008

Ds report a high and growing influence in decisions regarding the use of Sensipar. Treatment prevalence with Sensipar in hemodialysis patients, according to both MDs and RDs has been lingering at around 30%. While Sensipar is often used second line to Vitamin D, it does seem to impact Vitamin D dose, with the majority of RDs reporting that patients on Sensipar tend to be on lower doses of Vitamin D.

In the renal anemia market, Nephrologists seem to be settling into the new treatment standards (e.g., lower target hemoglobin levels, lower levels for ESA initiation, holds, and dose reductions) and more than two-thirds do not anticipate making any additional changes to their use of ESAs in CKD or dialysis. While Amgen's Epogen continues to dominate the dialysis market, there did seem to be some brand shifting between Amgen's Aranesp and Ortho Biotech's Procrit in CKD. Nephrologists do not predict significant changes in ESA market share in CKD or dialysis in the near-term, but they do project that bundling will have an impact on ESA use most likely through shifts to subcutaneous dosing and less aggressive treatment of EPO hypo-responders. New ESAs in development could also shift market dynamics particularly if these products are able to meet what Nephrologists identified as the most desired attributes in a new ESA.

In terms of IV iron, American Regent's Venofer remains the market leader in both dialysis and CKD, however, office-based Nephrologists report significantly higher CKD share for Venofer and hospital-based Nephrologists report significantly higher CKD share for Watson's Ferrlecit. In the dialysis market, very little brand switching took place in the past year, although 60% of Nephrologists primarily affiliated with Fresenius units expect their use of Venofer to increase following the news that Fresenius will be marketing and distributing Venofer in dialysis units. Awareness of AMAG Pharmaceutical's Ferumoxytol continues to be low. Among those famil
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
2. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
3. BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
4. New Study by BioTrends Highlights Practice Management Shifts Among European Nephrologists
5. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
7. T-System Releases The T SystemEV(R) 2.6.3, Featuring New Meds/Allergies Notification, Automated Charge Capture
8. BioWisdom Releases Text Analytics Version of OmniViz for Patent Specialists
9. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
10. Presidio Pay Advisors Releases Salary GPS Tool
11. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Earlier this year, Google announced the ... As this directly impacts the core component of the product, ... the most sweeping updates since its inception in October of ... posted a very informative article on the subject.. ... date for enhanced campaigns . Only recently, a ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 NuView Life ... imaging and in vitro diagnostic (IVD) biomarkers, today announced ... novel urine screen in development for the early detection ... presented in an oral presentation at the 2013 Annual ... Imaging (SNMMI) in Vancouver, Canada on Sunday, June 9th. ...
(Date:6/17/2013)... 17, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... R. Joseph as Chief Legal Officer.  Mr. Joseph ... experience and has worked in both public and private ... (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ) ... a general counsel and senior executive and his knowledge ...
(Date:6/17/2013)... zuChem Inc., a leading producer of ... today that the United States Patent and Trademark ... 8,367,346 entitled “Methods for Production of Xylitol in ... D-Mannitol." These two patents expand zuChem's technology portfolio ... products from abundant, renewable feedstocks. , The ...
Breaking Biology Technology:Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 2Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 3NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4zuChem Receives Two Polyol Patents 2
... -... -- DALLAS, Texas, September 3, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... , Sept. 2 For marketers everywhere, especially consumer ... of success, the question asked has now been definitively ... Scientist approached NeuroFocus to test three different cover designs ... crystallized what marketers around the globe want to know. ...
... RALEIGH, N.C., Sept. 2 Sicel Technologies, Inc., ... placed into involuntary bankruptcy. Effective August 31, 2010, ... interim Director of the company. Currently, Sicel,s operations ... been furloughed have returned to work.Media Contact: Lisa ...
Cached Biology Technology:New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 2New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 3New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 4New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 5New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 6New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 7New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets 8Sales Success Shows Neuromarketing Moves Magazines: New Scientist Reports 12% Increase in Newsstand Sales for Issue Featuring NeuroFocus-Tested Cover Design 2Sales Success Shows Neuromarketing Moves Magazines: New Scientist Reports 12% Increase in Newsstand Sales for Issue Featuring NeuroFocus-Tested Cover Design 3
(Date:6/18/2013)... Council, Laboratory of Molecular Biology, has been honored ... Investigator Award. Torrent is being recognized for his ... to predict antimicrobial regions in proteins. Luis Rivas, ... applying this algorithm to interrogate full genomes in ... very appealing results." , Torrent obtained his ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... nervous system infections may well be suffering from the ... study to be published in mBio , the ... Researchers have detected the virus in spinal fluid from ... infections of unknown cause, and in an average of ... suggesting animals may serve as reservoirs for transmission to ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... fruit tree grown in most Mediterranean-type climates. Although some ... species on earth, global expansion of fig crops has ... production practices and the limited number of fig cultivars ... the Mediterranean-type climate of Western Cape Province of South ...
... New Rochelle, NY, March 17, 2011A new research tool ... study the effects of miRNA on the early development ... disease mechanisms in humans, as described in Zebrafish, ... Inc. The article is available free online ahead of ...
... waste decaying down at the dump needs millions of years ... reactors, could pose an especially serious health risk should it ... years after its deposition. Now, researchers at the University of ... contained. The means? A particular kind of green goop that ...
Cached Biology News:Optimizing yield and fruit size of figs 2Green sludge can protect groundwater from radioactive contamination 2
... protein array systems, known as ChemiArrayTM ... useful compared with current methodologies. Besides ... Chemicons systems present a more accurate ... they only detect secreted cytokines, and ...
... The Easy Cap tool provides ... seat domed double-locking caps in tubes ... has a wide end that firmly ... prevent accidental crushing when opening or ...
... USP is a highly nutritious versatile medium ... Due to the inclusion of both Tryptone ... growth of many fastidious organisms without the ... to United States Pharmacopeia standards for use ...
...
Biology Products: